Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2010 1
2011 1
2013 1
2014 1
2017 1
2018 1
2020 1
2021 1
2022 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy.
Choi W, Porten S, Kim S, Willis D, Plimack ER, Hoffman-Censits J, Roth B, Cheng T, Tran M, Lee IL, Melquist J, Bondaruk J, Majewski T, Zhang S, Pretzsch S, Baggerly K, Siefker-Radtke A, Czerniak B, Dinney CP, McConkey DJ. Choi W, et al. Among authors: cheng t. Cancer Cell. 2014 Feb 10;25(2):152-65. doi: 10.1016/j.ccr.2014.01.009. Cancer Cell. 2014. PMID: 24525232 Free PMC article. Clinical Trial.
TCF21 Promotes Luminal-Like Differentiation and Suppresses Metastasis in Bladder Cancer.
Mokkapati S, Porten SP, Narayan VM, Lim AH, Jayaratna IS, Roth B, Cheng T, Navai N, Wszolek M, Melquist J, Manyam G, Choi W, Broom B, Pretzsch S, Czerniak B, McConkey DJ, Dinney CPN. Mokkapati S, et al. Among authors: cheng t. Mol Cancer Res. 2020 Jun;18(6):811-821. doi: 10.1158/1541-7786.MCR-19-0766. Epub 2020 Mar 2. Mol Cancer Res. 2020. PMID: 32122956
Feasible diet and circadian interventions reduce in vivo progression of FLT3-ITD-positive acute myeloid leukemia.
Rodriguez M, Fekry B, Murphy B, Figueroa M, Cheng T, Raber M, Wartenberg L, Bell D, Triche L, Crawford K, Ma H, Allton K, Ahmed R, Tran J, Ranieri C, Konopleva M, Barton M, Nunez C, Eckel-Mahan K, Chandra J. Rodriguez M, et al. Among authors: cheng t. Cancer Med. 2024 Jan;13(2):e6949. doi: 10.1002/cam4.6949. Cancer Med. 2024. PMID: 38334474 Free PMC article.
Effects of mTOR inhibitor everolimus (RAD001) on bladder cancer cells.
Chiong E, Lee IL, Dadbin A, Sabichi AL, Harris L, Urbauer D, McConkey DJ, Dickstein RJ, Cheng T, Grossman HB. Chiong E, et al. Among authors: cheng t. Clin Cancer Res. 2011 May 1;17(9):2863-73. doi: 10.1158/1078-0432.CCR-09-3202. Epub 2011 Mar 17. Clin Cancer Res. 2011. PMID: 21415218 Free PMC article.
11 results